North Star Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

North Star Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,766	Closed	-$245K	–	249
2016 Q4	$245K	Sell	6,766 -884	-12%	-$35.3K	0.03%	210
2016 Q3	$352K	Sell	7,650 -235	-3%	-$12.3K	0.04%	188
2016 Q2	$396K	Sell	7,885 -470	-6%	-$25K	0.05%	181
2016 Q1	$447K	Sell	8,355 -315	-4%	-$18.5K	0.05%	173
2015 Q4	$569K	Sell	8,670 -625	-7%	-$38.6K	0.07%	167
2015 Q3	$525K	Sell	9,295 -200	-2%	-$13K	0.07%	172
2015 Q2	$561K	Sell	9,495 -1,610	-14%	-$99.3K	0.06%	174
2015 Q1	$692K	Sell	11,105 -2,365	-18%	-$138K	0.08%	165
2014 Q4	$775K	Sell	13,470 -1,200	-8%	-$66.9K	0.09%	156
2014 Q3	$789K	Sell	14,670 -3,165	-18%	-$168K	0.09%	155
2014 Q2	$935K	Sell	17,835 -41,125	-70%	-$2.1M	0.11%	148
2014 Q1	$3.12M	Sell	58,960 -53,135	-47%	-$2.46M	0.37%	93
2013 Q4	$4.49M	Sell	112,095 -14,480	-11%	-$570K	0.54%	68
2013 Q3	$4.78M	Sell	126,575 -6,185	-5%	-$241K	0.63%	63
2013 Q2	$5.2M	Buy	+132,760	New	+$5.17M	0.73%	56

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

North Star Asset Management's TEVA Position: Q1 2017 in Review

North Star Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 6,766 shares — an estimated $245K sold.

North Star Asset Management first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $5.2M in Q2 2013. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

North Star Asset Management reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
North Star Asset Management sold 6,766 Teva Pharmaceuticals shares in Q1 2017, an estimated $245K.
North Star Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
North Star Asset Management's Teva Pharmaceuticals position peaked at $5.2M in Q2 2013.
686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on North Star Asset Management's 13F filing for Q1 2017, filed 18 May 2017.